» Articles » PMID: 30389231

Hepatic Growth Hormone - JAK2 - STAT5 Signalling: Metabolic Function, Non-alcoholic Fatty Liver Disease and Hepatocellular Carcinoma Progression

Overview
Journal Cytokine
Date 2018 Nov 4
PMID 30389231
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The rising prevalence of obesity came along with an increase in associated metabolic disorders in Western countries. Non-alcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of the metabolic syndrome and is linked to primary stages of liver cancer development. Growth hormone (GH) regulates various vital processes such as energy supply and cellular regeneration. In addition, GH regulates various aspects of liver physiology through activating the Janus kinase (JAK) 2- signal transducer and activator of transcription (STAT) 5 pathway. Consequently, disrupted GH - JAK2 - STAT5 signaling in the liver alters hepatic lipid metabolism and is associated with NAFLD development in humans and mouse models. Interestingly, while STAT5 as well as JAK2 deficiency correlates with hepatic lipid accumulation, recent studies suggest that these proteins have unique ambivalent functions in chronic liver disease progression and tumorigenesis. In this review, we focus on the consequences of altered GH - JAK2 - STAT5 signaling for hepatic lipid metabolism and liver cancer development with an emphasis on lessons learned from genetic knockout models.

Citing Articles

Risk factors and prediction model of metabolic disorders in adult patients with pituitary stalk interruption syndrome.

Jiang D, Wang S, Xiao Y, Zhi P, Zheng E, Lyu Z Sci Rep. 2025; 15(1):7740.

PMID: 40044792 PMC: 11882961. DOI: 10.1038/s41598-025-91461-7.


Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progression.

Sonkar R, Ma H, Waxman D Toxicol Sci. 2024; 200(2):324-345.

PMID: 38710495 PMC: 11285164. DOI: 10.1093/toxsci/kfae057.


Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer.

Jia J, Zhou X, Chu Q Mol Cell Biochem. 2024; 480(1):1-17.

PMID: 38519710 DOI: 10.1007/s11010-024-04983-5.


Plasma growth hormone pulses induce male-biased pulsatile chromatin opening and epigenetic regulation in adult mouse liver.

Rampersaud A, Connerney J, Waxman D Elife. 2023; 12.

PMID: 38091606 PMC: 10721219. DOI: 10.7554/eLife.91367.


Association Between Polymorphisms and the Risk of Diabetes Mellitus in Hypertensive Patients.

Zeng M, Liu Y, Xie Y Int J Gen Med. 2023; 16:5719-5727.

PMID: 38084269 PMC: 10710740. DOI: 10.2147/IJGM.S435598.